Imperial College London

DrVerityLeeson

Faculty of MedicineDepartment of Brain Sciences

Clinical Trials Manager
 
 
 
//

Contact

 

+44 (0)20 3313 4133v.leeson

 
 
//

Location

 

Clinical Trials OfficeCommonwealth BuildingHammersmith Campus

//

Summary

 

Summary

Verity Leeson oversees the management of a portfolio of clinical trials in mental health, the majority of which involve the assessment of investigative medicinal products. This entails supervising a small team of trial coordinators, monitors and administrative staff to ensure the safe conduct of the trials with adherence to necessary pharmacovigilance. Day-to-day responsibilities include protocol and other document writing, preparation of ethical and regulatory submissions, proactive risk identification and supporting issue resolution, managing the budget and contractual arrangements, and collaboration on the development of new projects including funding applications.

Selected Publications

Journal Articles

Crawford MJ, Sanatinia R, Barrett B, et al., 2018, The clinical effectiveness and cost effectiveness of lamotrigine for people with borderline personality disorder: a randomized, placebo-controlled trial, American Journal of Psychiatry, Vol:175, ISSN:0002-953X, Pages:756-764

Barnes TRE, Leeson V, Paton C, et al., 2018, Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial, Therapeutic Advances in Psychopharmacology, Vol:8, ISSN:2045-1253, Pages:185-197

Barnes TRE, Leeson VC, Paton C, et al., 2017, Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness, Health Technology Assessment, Vol:21, ISSN:1366-5278, Pages:1-+

Barnes TR, Leeson VC, Paton C, et al., 2016, Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial, Health Technology Assessment, Vol:20, ISSN:1366-5278

Leeson VC, Tyrer P, 2013, The advance of research governance in psychiatry: one step forward, two steps back, Epidemiology and Psychiatric Sciences, Vol:22, ISSN:2045-7960, Pages:313-320

Galve LBG, Wheeler-Kingshott CAM, Altmann DR, et al., 2012, CORTICAL THINNING OVER TWO YEARS FOLLOWING THE FIRST EPISODE OF PSYCHOSIS: RELATIONSHIP TO TREATMENT DURATION AND COGNITIVE IMPAIRMENT, Schizophrenia Research, Vol:136, ISSN:0920-9964, Pages:S205-S205

Leeson VC, Sharma P, Harrison M, et al., 2011, IQ Trajectory, Cognitive Reserve, and Clinical Outcome Following a First Episode of Psychosis: A 3-Year Longitudinal Study, Schizophrenia Bulletin, Vol:37, ISSN:0586-7614, Pages:768-777

Leeson VC, Harrison I, Ron MA, et al., 2011, The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia, Schizophrenia Bulletin

Barnett JH, Robbins TW, Leeson VC, et al., 2010, Assessing cognitive function in clinical trials of schizophrenia, Neuroscience and Biobehavioral Reviews, Vol:34, ISSN:0149-7634, Pages:1161-1177

Leeson VC, Robbins TW, Franklin C, et al., 2009, Dissociation of long-term verbal memory and fronto-executive impairment in first-episode psychosis, Psychological Medicine, Vol:39, ISSN:0033-2917, Pages:1799-1808

Leeson VC, Robbins TW, Matheson E, et al., 2009, Discrimination Learning, Reversal, and Set-Shifting in First-Episode Schizophrenia: Stability Over Six Years and Specific Associations with Medication Type and Disorganization Syndrome, Biological Psychiatry, Vol:66, ISSN:0006-3223, Pages:586-593

More Publications